The use of controlled drug delivery systems could give a significant contribution to the improvement of therapies against biofilm-based infections. The aim of this study was to develop polymer microparticles, based on carboxylated poly(l-lactide)s, to be employed as carriers for usnic acid (UA), a poorly soluble drug possessing antiviral, antiproliferative and wide spectrum antimicrobial activity. Thanks to polymer surfactant-like structure, 2.4 μm-in-size microparticles were obtained by a surfactant-free oil-in-water emulsion/evaporation method. UA was encapsulated into these microparticles with a high loading efficiency (80%). The drug release kinetics was found to be temperature dependent (the released dose increasing with temperature) a...
Bacterial biofilms are associated with a number of recurring infectious diseases and are a major cau...
The sustained release of pharmaceutical substances remains the most convenient way of drug delivery....
Nosocomial infections remain a serious threat even for patients of highly industrialized countries. ...
In modern medicine, medical devices are used for different applications, including the repair or rep...
Controlled and sustained release of antibacterial drugs is a promising approach to address challenge...
Artificial surfaces of implanted medical devices can be often colonized by bacteria and fungi. Once ...
In modern medicine, artificial devices are used for repair or replacement of damaged parts of the bo...
Because of the increased incidence of infections caused by resistant pathogens, due to the intensive...
Our research was focused to the evaluation of the activity of usnic acid, a secondary lichen metabol...
Biofilms are surface-bound, structured microbial communities underpinning persistent bacterial infec...
Abstract Staphylococcus aureus is a unique challenge for the healthcare system because it can form b...
Polymeric microparticles are widely used in drug delivery systems due to their biocompatibility as w...
Inês Santos Ferreira,1 Ana F Bettencourt,1 Lídia MD Gonçalves,1 Stefanie Kasper,...
The aim of this study was to produce biocompatibile microparticles for the mucosal administration of...
Bacterial infections are a cause of numerous illnesses and deaths in the world. Although numerous an...
Bacterial biofilms are associated with a number of recurring infectious diseases and are a major cau...
The sustained release of pharmaceutical substances remains the most convenient way of drug delivery....
Nosocomial infections remain a serious threat even for patients of highly industrialized countries. ...
In modern medicine, medical devices are used for different applications, including the repair or rep...
Controlled and sustained release of antibacterial drugs is a promising approach to address challenge...
Artificial surfaces of implanted medical devices can be often colonized by bacteria and fungi. Once ...
In modern medicine, artificial devices are used for repair or replacement of damaged parts of the bo...
Because of the increased incidence of infections caused by resistant pathogens, due to the intensive...
Our research was focused to the evaluation of the activity of usnic acid, a secondary lichen metabol...
Biofilms are surface-bound, structured microbial communities underpinning persistent bacterial infec...
Abstract Staphylococcus aureus is a unique challenge for the healthcare system because it can form b...
Polymeric microparticles are widely used in drug delivery systems due to their biocompatibility as w...
Inês Santos Ferreira,1 Ana F Bettencourt,1 Lídia MD Gonçalves,1 Stefanie Kasper,...
The aim of this study was to produce biocompatibile microparticles for the mucosal administration of...
Bacterial infections are a cause of numerous illnesses and deaths in the world. Although numerous an...
Bacterial biofilms are associated with a number of recurring infectious diseases and are a major cau...
The sustained release of pharmaceutical substances remains the most convenient way of drug delivery....
Nosocomial infections remain a serious threat even for patients of highly industrialized countries. ...